PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2020
CASE
AUTH/3390/9/20 Janssen

Janssen: UK employee’s LinkedIn post about unlicensed Covid-19 vaccine candidate ruled pre-authorisation promotion (AUTH/3390/9/20)

A Janssen UK employee reposted/commented on a US exec’s LinkedIn update about a Covid-19 vaccine candidate entering Phase 3. Panel ruled pre-authorisation…

2019
CASE
Britannia

Britannia advisory boards for Apo-Go: poor governance and record-keeping led to Clause 9.1 and 23.1 breaches

Ex-employee alleged Apo-Go advisory boards were promotional. Panel found high standards breach (9.1). On appeal, poor documentation, SOP deviations and missing minutes…

2019
CASE
Pfizer

Pfizer: Senior employee’s LinkedIn post linking to BBC β€˜vaccine judged safe’ headline breached ABPI Code

A senior Pfizer UK employee posted a proud LinkedIn message linking to a BBC article with an unqualified β€œsafe” headline about the…

2021
CASE
AUTH/3468/2/21 Sanofi

Sanofi breached ABPI Code after uncertified internal email to salesforce about Toujeo patient materials and digital campaigns (AUTH/3468/2/21)

An internal salesforce email mixing patient booklet availability with digital campaign screenshots wasn’t itself improper, but it was treated as rep briefing/instructions…

2020
CASE
AUTH/3414/11/20 Novartis Pharmaceuticals UK ⭐ Case of the Week

Novartis: corporate webpage pipeline table ruled to promote POMs to the public and an unlicensed medicine (AUTH/3414/11/20)

Novartis’ corporate webpage listed pipeline products with indications and trial details. PMCPA ruled it promoted two licensed POMs to the public and…

2021
CASE
AUTH/3465/2/21 Vifor Pharma

AUTH/3465/2/21: Complainant v Vifor β€” Venofer symposium and alleged off-licence promotion (No breach)

Anonymous UK health professional alleged a Vifor-sponsored PIVOTAL sub-analysis symposium promoted off-licence Venofer use. Panel found PIVOTAL dosing aligned with clinically accepted…

2021
CASE
AUTH/3498/3/21 Leo

LEO Pharma: late and incomplete disclosure of patient organisation support (AUTH/3498/3/21)

Ex-employee alleged errors/omissions in LEO’s patient organisation support list. PMCPA found late disclosure of 2019 payments and an omitted donation; Clause 2…

2020
CASE
AUTH/3411/10/20 AstraZeneca

Daiichi Sankyo & AstraZeneca: UK employees’ LinkedIn β€˜likes’ brought US trial post into UK Code scope (AUTH/3411/10/20, AUTH/3412/10/20)

UK employees β€˜liked’ a US LinkedIn post linking to an Enhertu Phase 3 trial press release. Panel said the β€˜likes’ proactively disseminated…

2020
CASE
AUTH/3436/12/20 Janssen

Janssen: Stelara homecare service ran for 28 months without oversight, triggering Clause 2 and public reprimand (AUTH/3436/12/20)

Janssen admitted it failed to oversee a nurse-led Stelara homecare service that continued after β€œtermination”, with missing contracts, inadequate vendor PV/product training…

2021
CASE
AUTH/3521/6/21 AstraZeneca ⭐ Case of the Week

AstraZeneca: β€œNon-promotional” EAP webinar ruled promotional and disguised promotion (Calquence) (AUTH/3521/6/21)

An invitation-only Calquence EAP β€œnon-promotional” webinar used positive case studies and lacked certified slides. PMCPA ruled it was promotional material and that…

2021
CASE
AUTH/3558/9/21 Sanofi

Sanofi employee complaint about β€œinsight gathering” (KAM calls and virtual EKC event): no breach (AUTH/3558/9/21)

Anonymous employee alleged KAM β€œinsights” sharing raised GDPR and covert marketing insight concerns, plus a training event shifting to insight gathering. Panel…

2021
CASE
AUTH/3525/6/21 Novo Nordisk

Novo Nordisk: LinkedIn-promoted β€œfree” weight management course and funded Saxenda PGDs ruled disguised promotion and inducement (AUTH/3525/6/21)

Novo Nordisk-sponsored obesity training promoted Saxenda via LinkedIn without clear upfront sponsorship, certification or prescribing info. Funding Β£79 Saxenda PGDs for HCPs…

2021
CASE
AUTH/3584/11/21 Roche Products

Roche LinkedIn β€˜Experience’ sections: references to POMs ruled not promotional (No breach) | AUTH/3584/11/21

Health professional alleged Roche employees’ LinkedIn β€˜Experience’ sections promoted POMs without mandatory info. Panel and Appeal Board found the content was CV-style,…

2022
CASE
AUTH/3617/3/22 GlaxoSmithKline

GSK employee’s personal LinkedIn post about β€œshingles prevention” and Shingrix role: no breach (AUTH/3617/3/22)

Complaint alleged Shingrix promotion on an employee’s personal LinkedIn post/profile. Panel found no promotion to the public or HCPs and ruled no…

2022
CASE
AUTH/3653/5/22 Novo Nordisk ⭐ Case of the Week

AUTH/3653/5/22: Eli Lilly v Novo Nordisk β€” GLP-1RA supply emails ruled disparaging (Clause 6.6)

Novo Nordisk emailed HCPs about GLP-1RA supply during Lilly’s Trulicity dose outage. Panel found the wording implied Lilly didn’t prioritise supply, breaching…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training